Skip to main content
blood vials

Bloodborne Pathogens

SARS-CoV-2 or COVID-19 Related Research

Please let your Biosafety Officer know of ANY SARS-CoV-2 or COVID-19 related research you were approved to conduct by your PI, DLCI Head and MIT Administration, or are planning to submit. Most of the research involving recombinant parts of SARS-CoV-2, SARS-CoV (also referred to as SARS-CoV-1), or MERS-CoV requires registration with the CAB (MIT Committee on Assessment of Biohazards & Embryonic Stem Cell Research Oversight). Please plan accordingly and email BSP@mit.edu for a proper risk assessment.

The Occupational Safety and Health Administration’s Bloodborne Pathogens Standard, OSHA BBP Standard, was promulgated in 1991.The standard was issued to protect employees from occupational exposure to bloodborne pathogens, including but not limited to, the Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV). The regulation requires that employers have a written Exposure Control Plan (ECP) and that employees with occupational exposures to human materials understand how to prevent on-the-job exposures, be offered the Hepatitis B vaccine, and receive training prior to the start of any work, and annual re-training thereafter. Contact your Principal Investigator (PI) or supervisor to find out if your lab or group is included in the program.

Each lab or group with occupational exposure must have an Exposure Control Plan checklist and received training on their Exposure Control Plan (ECP) checklist.

Download Generic ECP checklist

Recommended biosafety precautions for working with primary human material due to COVID-19 (For samples not known to be infected with SARS-CoV-2)

The Occupational Safety and Health Administration’s Bloodborne Pathogens Standard, OSHA BBP Standard, was promulgated in 1991.The standard was issued to protect employees from occupational exposure to bloodborne pathogens, including but not limited to, the Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV). The regulation requires that employers have a written Exposure Control Plan (ECP) and that employees with occupational exposures to human materials understand how to prevent on-the-job exposures, be offered the Hepatitis B vaccine, and receive training prior to the start of any work, and annual re-training thereafter. Contact your Principal Investigator (PI) or supervisor to find out if your lab or group is included in the program.

Each lab or group with occupational exposure must have an Exposure Control Plan checklist and received training on their Exposure Control Plan (ECP) checklist.

Download Generic ECP checklist

Recommended biosafety precautions for working with primary human material due to COVID-19 (For samples not known to be infected with SARS-CoV-2)